ESTABLISHMENT LABS HOLDINGS (ESTA)
VGG312491084 - Common Stock
Taking everything into account, ESTA scores 3 out of 10 in our fundamental rating. ESTA was compared to 188 industry peers in the Health Care Equipment & Supplies industry. ESTA may be in some trouble as it scores bad on both profitability and health. While showing a medium growth rate, ESTA is valued expensive at the moment.
1. Profitability
1.1 Basic Checks
In the past year ESTA has reported negative net income.
ESTA had a negative operating cash flow in the past year.
ESTA had negative earnings in each of the past 5 years.
In the past 5 years ESTA always reported negative operating cash flow.
1.2 Ratios
With a Return On Assets value of -29.18%, ESTA perfoms like the industry average, outperforming 45.45% of the companies in the same industry.
ESTA has a Return On Equity of -184.80%. This is in the lower half of the industry: ESTA underperforms 78.61% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -29.18% | ||
| ROE | -184.8% | ||
| ROIC | N/A |
ROA(3y)-31.44%
ROA(5y)-30.29%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
The Gross Margin of ESTA (66.04%) is better than 68.98% of its industry peers.
In the last couple of years the Gross Margin of ESTA has grown nicely.
ESTA does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 66.04% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.48%
GM growth 5Y1.89%
2. Health
2.1 Basic Checks
ESTA does not have a ROIC to compare to the WACC, probably because it is not profitable.
ESTA has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, ESTA has more shares outstanding
Compared to 1 year ago, ESTA has an improved debt to assets ratio.
2.2 Solvency
ESTA has an Altman-Z score of 1.67. This is a bad value and indicates that ESTA is not financially healthy and even has some risk of bankruptcy.
ESTA has a Altman-Z score of 1.67. This is comparable to the rest of the industry: ESTA outperforms 54.01% of its industry peers.
A Debt/Equity ratio of 4.30 is on the high side and indicates that ESTA has dependencies on debt financing.
ESTA has a worse Debt to Equity ratio (4.30) than 88.77% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 4.3 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 1.67 |
ROIC/WACCN/A
WACC8.63%
2.3 Liquidity
A Current Ratio of 4.44 indicates that ESTA has no problem at all paying its short term obligations.
The Current ratio of ESTA (4.44) is better than 68.98% of its industry peers.
ESTA has a Quick Ratio of 2.91. This indicates that ESTA is financially healthy and has no problem in meeting its short term obligations.
ESTA has a Quick ratio of 2.91. This is in the better half of the industry: ESTA outperforms 63.10% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 4.44 | ||
| Quick Ratio | 2.91 |
3. Growth
3.1 Past
The earnings per share for ESTA have decreased strongly by -27.46% in the last year.
The Revenue for ESTA has decreased by -14.56% in the past year. This is quite bad
The Revenue has been growing by 21.96% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-27.46%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%4.62%
Revenue 1Y (TTM)-14.56%
Revenue growth 3Y24.93%
Revenue growth 5Y21.96%
Sales Q2Q%-9.15%
3.2 Future
ESTA is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 20.18% yearly.
The Revenue is expected to grow by 25.00% on average over the next years. This is a very strong growth
EPS Next Y22.59%
EPS Next 2Y26.07%
EPS Next 3Y24.19%
EPS Next 5Y20.18%
Revenue Next Year6.01%
Revenue Next 2Y19.85%
Revenue Next 3Y23.12%
Revenue Next 5Y25%
3.3 Evolution
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
4. Valuation
4.1 Price/Earnings Ratio
ESTA reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for ESTA. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
ESTA's earnings are expected to grow with 24.19% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y26.07%
EPS Next 3Y24.19%
5. Dividend
5.1 Amount
No dividends for ESTA!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
ESTABLISHMENT LABS HOLDINGS
NASDAQ:ESTA (11/4/2024, 8:05:50 PM)
After market: 46.76 0 (0%)46.76
+1.34 (+2.95%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap1.31B
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -29.18% | ||
| ROE | -184.8% | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 66.04% | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.53
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 4.3 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 4.44 | ||
| Quick Ratio | 2.91 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)-27.46%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next Y22.59%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-14.56%
Revenue growth 3Y24.93%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y